CED Announces Venture Connect 2020 Presenting Companies

RTP, NC January 17, 2020 – The Council for Entrepreneurial Development (CED) today announced the tech and life science companies that have been selected to present at Venture Connect Summit 2020, to be held March 17-19 in Raleigh, NC.   

Click here to view the profiles

“We had a record year this year with an overwhelming response in applications received. It’s going to be an amazing Summit with a building list of over 125 tech and life science companies on stage,” says Miriam Wison, SVP of CED.  

Companies will take the stage to present their big ideas in front of a captive audience and potential investors. Venture Connect is the future of tech and life science and an opportunity to grow brand awareness and gain valuable insight on educational topics. We expect over 1400 attendees, over 200 investors and countless valuable connections to be made.      

Presenting companies were chosen by a selection committee made up of community members, including active angel investors, local and regional venture capital firms, community and corporate partners.

You will find a diverse selection of presenting companies at Venture Connect including: AI,  Augmented Reality, Big Data, Cyber Security, E-Commerce, Smart Devices, Digital Health, Healthy Consumer,  Therapeutics, Advanced Diagnostics, Med Device, Ag Tech and more. 

2020 Venture Connect Presenting Companies: 

Adzerk

Allstacks

Applied LifeSciences and Systems Poultry, Inc.

Arrevus

Baebies, Inc.

Cell Microsystems, Inc

Cereius, Inc

CrediVia

Diveplane CorporationEasyVote Solutions 

Enzerna Biosciences, Inc

Evecxia, Inc.

EydisBio, Inc.

Gavilan Biodesign

Gemelli Biotech

IMMvention Therapeutix, Inc

Keen Decision Systems

LearnPlatform

Lindy Biosciences, Inc.

Metabolon, Inc.

Nufabrx

NuPulseCV

ProAxion Inc

RFPI, Inc.

SENTIO

StrongKey

Tellus Therapeutics, Inc.

The Climate Service

Veralox Therapeutics, Inc.

Viatec, Inc.

Voxelight LLC

Wellnecity

ZynBit

6AM City LLC

Achelios Therapeutics

Advanced Chemotherapy Technologies

Advanced Nanocoatings Incorporated

AgEye Technologies

Altis Biosystems, Inc.

AnelleO, Inc.

Aniluxx Biotechnology

Aptus Bioreactors

Ares Immunotherapy

Arpio

Avior Bio Inc

Basking Biosciences, inc

Betr Health

BioAesthetics

BioLink Life Sciences, Inc

BiomedInnovations LLC

Blue Eye Soft Corp

BlueRecruit, Inc.

Bundle

CAARMO

CARL, Inc.

CERCA

CourtRoom5

Coworks

Cytex Therapeutics, Inc.

DataClarity Corporation

DermiSense Inc

Elevon

EncepHEAL Therapeutics

Equity Shift

EternaTear

FeedStation

Floodlight Software

Flow ROI

Green Stream Technologies Inc

Hank AI, Inc

Home Lending Pal 

Intake

LabVoice

mesur.io, Inc

Metallum3D Inc

MicroElastic Ultrasound Systems

MuukLabs

MycoMed Technologies

NALA Systems, Inc.

Newsco Inc

One Donation 

OpiAID, LLC

PERMITS.com

Phase Dock, Inc.

PhosphoGam

Plakous Therapeutics, Inc.

Plan2Play

Point Motion Inc.

PrimeNeuro

Protect3d

Protopia

QATCH Technologies

Redbud Labs

Reflekt Me, inc.

RelayOne

Renovian, Inc.

Revibe Technologies

Snthesis Inc

Sparta BioMedical Inc.

Squirrel Compliancy Solutions, Inc.

Startomatic 

Sunder Networks

Sweetie Pie Organics

Swell Systems, Inc.

Threat Sketch, LLC

Trio Labs

TRPBlue Inc.

Tunnel International Inc

URO-1, Inc.

Venti LLC

VitalFlo Inc.

Xilis, Inc.

Click here to view profiles.

Register for Venture Connect 

Registration is OPEN and will run through March 11. Early ticket prices are $350 for entrepreneurs and $650 for General attendees. A ticket will include – three days of nonstop content, a keynote lunch, networking receptions, one-on-one meeting access, and more. Regular rates begin on February 15 and prices increase to $500 and $950 respectively, so get your tickets early! Visit the CED website to purchase tickets and for further information.

The conference is presented in partnership with the North Carolina Biotechnology Center and the North Carolina Biosciences Organization.

Media interested in attending the conference should contact Kristina Sandine at ksandine@cednc.org or 919-226-0470.

get the latest

X
X